Desvenlafaxine succinate Good Manufacturer supply High Quality 386750-22-7
- Molecular Formula:C16H25NO2.C4H6O4.H2O
- Molecular Weight:399.485
- Appearance/Colour:White crystalline powder
- Vapor Pressure:3.03E-07mmHg at 25°C
- Boiling Point:403.8 °C at 760 mmHg
- Flash Point:193.2 °C
- PSA：118.30000
- LogP:2.66840
Desvenlafaxine succinate (386750-22-7) Usage
Desvenlafaxine Succinate is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that was approved for the treatment of major depressive disorder (MDD) in the United States in 2008. In order to improve the efficacy and safety profile of venlafaxine, Wyeth discovered and developed one of the major metabolites of venlafaxine, namely the O-desmethyl metabolite (desvenlafaxine). Desvenlafaxine is also being developed for the treatment of moderate to severe vasomotor symptoms associated with menopause (i.e., hot flashes and night sweats) and is also in phase III clinical trials to study it’s effectiveness in treating fibromyalgia and neuropathic pain.
How to get the best price on Desvenlafaxine succinate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Desvenlafaxine succinate . You can buy high quality, low price Desvenlafaxine succinate 386750-22-7 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
